http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18106051

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1391
issn 0923-7534
issueIdentifier 6
pageRange 1382-1391
publicationName Annals of oncology : official journal of the European Society for Medical Oncology
startingPage 1382
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bec8928455350d333f8b5b9d333114a7
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_239dec50a197cf8cabf7f46241922df0
bibliographicCitation Ohmachi K, Tobinai K, Kobayashi Y, Itoh K, Nakata M, Shibata T, Morishima Y, Ogura M, Suzuki T, Ueda R, Aikawa K, Nakamura S, Fukuda H, Shimoyama M, Hotta T; members of the Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG-LSG). Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809. Ann Oncol. 2011 Jun;22(6):1382–91. doi: 10.1093/annonc/mdq619. PMID: 21196441.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb4011b03cf18667e942eac864161c8b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_890c2a0ee4853bc3feedc469987a1058
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38cd131cf15f56d093be6f502dfa4555
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce835c4a4444718e8d05bef84453a6e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40bc8aec0701506b75689f083d0befbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a91f0110ead1b3e3c4b5760e205bb966
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f76490fbb238d05ae61e434d04587d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b4901a6654ff0af67ecbc8382a4ba96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f1d0636e999d0f47d25da880cc77dd4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71690497452482f233c1646f6d44badc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c6b317768611b9e06a321758e90f3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a16306df586022109ced28fd462bc63
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e00d398e4643002856c8dd6016b04fbd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b64213b843f7f8e94bc0abdf9e24dae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61659774d8a810c4b3564bcf8a5f3406
date 201106
identifier https://pubmed.ncbi.nlm.nih.gov/21196441
https://doi.org/10.1093/annonc/mdq619
isPartOf https://portal.issn.org/resource/ISSN/0923-7534
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809
discusses http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0022676
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D008228Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007564
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D014750Q000008
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D003520Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D003520Q000009
http://id.nlm.nih.gov/mesh/D014750Q000009
http://id.nlm.nih.gov/mesh/D014750Q000627
http://id.nlm.nih.gov/mesh/D003520Q000008
http://id.nlm.nih.gov/mesh/D004317Q000627
http://id.nlm.nih.gov/mesh/D000971Q000009
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D004317Q000009
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004317Q000008
http://id.nlm.nih.gov/mesh/D011241Q000008
http://id.nlm.nih.gov/mesh/D008228Q000473
http://id.nlm.nih.gov/mesh/D011241Q000627
http://id.nlm.nih.gov/mesh/D011241Q000009
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000293

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 67.